As new medications are approved for patients with allergies and asthma it becomes more important that doctors are able to provide them with the key information about these therapies and what it can mean for their overall care.
Many pulmonologists when treating a patient could focus their attention either on asthma or COPD. However, a growingly common patient pool is emerging with symptoms resulting from a combination of the two difficult conditions.
For patients with seasonal allergies the prescription medications available may not be enough to help with their symptoms and shots may not be an option they want to consider. Newly developed sublingual immunotherapies have been developed to help these patients manage their daily lives.